Icon price target raised to $308 from $304 at Baird

Baird analyst Eric Coldwell raised the firm’s price target on Icon to $308 from $304 and keeps an Outperform rating on the shares. The firm noted they provided 2024 guidance in advance of a presentation at a healthcare conference. Guidance came directionally as expected, with solid margin expansion expectations and net favorable non-operating items offsetting moderately lower midpoint revenue growth and driving EPS midpoint modestly above Baird and Street.